Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Myocardial Remodeling	3/51	0.001377254667314228	0.21772644796618956	0	0	14.95933734939759	98.54707514703038	MYC;TIMP2;PTK2B
Proteins Involved in Glioma	6/290	0.0015720103663818836	0.21772644796618956	0	0	5.183978873239437	33.4646571696134	CYP27B1;IGFBP5;PLAU;MYC;PTK2B;HOXB2
TRPM8 Effects in Prostate Cancer (Hypothesis)	2/15	0.0018503664133103928	0.21772644796618956	0	0	36.44871794871795	229.34887761330484	MYC;PTK2B
Proteins Involved in Prostate Cancer	4/138	0.0029757163932822616	0.2601297229488897	0	0	7.20058245358573	41.887735634503564	IGFBP5;PLAU;MYC;PTK2B
Endothelin Signaling in Arterial Hypertension	2/27	0.005982042701273519	0.2601297229488897	0	0	18.941904761904762	96.96348130198568	MYC;PTK2B
Glutamine in Cancer Metabolism	2/28	0.006424304780695358	0.2601297229488897	0	0	18.21245421245421	91.93040155644884	MYC;GOT2
Vitamine D Deficite and Dentin Formation	2/31	0.007837281084236711	0.2601297229488897	0	0	16.325944170771756	79.16227161319938	CYP27B1;PTK2B
Aldosterone Synthesis Chronic Regulation	2/31	0.007837281084236711	0.2601297229488897	0	0	16.325944170771756	79.16227161319938	MYC;PTK2B
Endothelial Cell Dysfunction in Arterial Hypertension	2/32	0.008336574343939954	0.2601297229488897	0	0	15.780952380952382	75.54504286216243	MYC;PTK2B
Tumor Infiltrating Macrophages in Cancer Progression and Immune Escape	2/36	0.010471871180313822	0.2601297229488897	0	0	13.92156862745098	63.469302191660454	PLAU;VTCN1
PDGFR -> AP-1/MYC Signaling	2/37	0.011039601287524271	0.2601297229488897	0	0	13.52312925170068	60.938822348351906	MYC;PTK2B
HGFR -> AP-1/CREB/MYC Signaling	2/38	0.011620646525927768	0.2601297229488897	0	0	13.146825396825397	58.56873758614498	MYC;PTK2B
Proteins Involved in Stem Cell Exhaustion in Aging	2/39	0.012214884664152803	0.2601297229488897	0	0	12.790862290862291	56.345027688088976	IGFBP5;MYC
TRPM4/6/7/8 Signaling in Arterial Hypertension (Hypothesis)	2/39	0.012214884664152803	0.2601297229488897	0	0	12.790862290862291	56.345027688088976	MYC;PTK2B
Telomer Attrition Triggers Genomic Instability	2/40	0.012822194254667357	0.2601297229488897	0	0	12.453634085213032	54.2552243331824	TEP1;MYC
Mesangial Cell Dysfunction in Glomerulonephritis	2/41	0.01344245462757058	0.2601297229488897	0	0	12.133699633699633	52.28820471678212	MYC;PTK2B
VEGFR -> AP-1/CREB/MYC Signaling	2/43	0.014721348919376426	0.2601297229488897	0	0	11.540650406504065	48.68373208317524	MYC;PTK2B
Prostate Cancer	3/123	0.01604275901928787	0.2601297229488897	0	0	5.962048192771085	24.638150340484763	IGFBP5;MYC;PTK2B
EGFR -> AP-1/CREB/ELK/SRF/MYC Signaling	2/49	0.018856539279652515	0.2601297229488897	0	0	10.064336372847011	39.96442815292184	MYC;PTK2B
Mesangial Cell Dysfunction in Diabetic Nephropathy	2/49	0.018856539279652515	0.2601297229488897	0	0	10.064336372847011	39.96442815292184	MYC;PTK2B
Smooth Muscle Cell Dysfunction in Arterial Hypertension	2/50	0.019588053045278837	0.2601297229488897	0	0	9.854166666666666	38.754815869716495	MYC;PTK2B
NTRK -> AP-1/CREB/ELK/SRF/MYC/SMAD3/TP53 Signaling	2/51	0.020331352819639298	0.2601297229488897	0	0	9.652575315840622	37.60248659414546	MYC;PTK2B
HPV E5 Regulates EDNRA and EGFR Signaling Pathway in Keratinocytes	2/53	0.021852861604271988	0.2601297229488897	0	0	9.27310924369748	35.45502287445614	MYC;PTK2B
FGFR -> AP-1/CREB/CREBBP/ELK/SRF/MYC Signaling	2/54	0.02263084804050612	0.2601297229488897	0	0	9.094322344322345	34.453306781873835	MYC;PTK2B
Airway Smooth Muscle Cell High Rate Proliferation	2/54	0.02263084804050612	0.2601297229488897	0	0	9.094322344322345	34.453306781873835	MYC;PTK2B
Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway	2/55	0.023420175322827873	0.2601297229488897	0	0	8.922282120395328	33.49565175775767	IGFBP5;MYC
Proteins Involved in Arterial Hypertension	4/255	0.02429499506950633	0.2601297229488897	0	0	3.821397337479351	14.205986952735376	MYC;KCNMA1;NFATC3;PTK2B
Effector T-cell Inactivation in Cancer Immune Escape	2/58	0.025855110939157076	0.2601297229488897	0	0	8.443027210884354	30.86134973425539	PTK2B;VTCN1
Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma	2/58	0.025855110939157076	0.2601297229488897	0	0	8.443027210884354	30.86134973425539	MYC;PTK2B
Proliferative Diabetic Retinopathy	2/60	0.0275331172249705	0.2601297229488897	0	0	8.151067323481117	29.281614965730913	PLAU;MYC
UrokinaseR -> STAT Signaling	1/7	0.029718695945433443	0.2601297229488897	0	0	39.03529411764706	137.24727196053433	PLAU
EGFR Transactivation in Cancer and Non-Cancer Cells	2/63	0.030130074139429686	0.2601297229488897	0	0	7.749024199843872	27.138876377223244	MYC;PTK2B
Metabolic Reprogramming in Cancer: Overview	2/63	0.030130074139429686	0.2601297229488897	0	0	7.749024199843872	27.138876377223244	MYC;ME1
Cardiomyocyte Hypertrophy	2/65	0.031913456894228094	0.2601297229488897	0	0	7.5022675736961455	25.843267512966868	TIMP2;PTK2B
Skin Fibrosis	2/67	0.033737540369749436	0.2601297229488897	0	0	7.270695970695971	24.64143638145943	TIMP2;PTK2B
Selencompound Biosynthesis	1/8	0.03389235304552857	0.2601297229488897	0	0	33.457142857142856	113.23790361856584	PAPSS2
Microtubule Organization Dysregulation (Hypothesis)	1/8	0.03389235304552857	0.2601297229488897	0	0	33.457142857142856	113.23790361856584	EPM2A
Androgen Receptor Coregulator ARA55 (TGFB1I1) in Prostate Cancer	1/8	0.03389235304552857	0.2601297229488897	0	0	33.457142857142856	113.23790361856584	PTK2B
Proteins Involved in Glioblastoma	3/178	0.04146268740817141	0.2601297229488897	0	0	4.0769018932874355	12.976621173544334	PLAU;MYC;TIMP2
MHC2-Mediated Antigen Presentation	1/10	0.0421865092184754	0.2601297229488897	0	0	26.019607843137255	82.36909635390154	HLA-DMB
Argininosuccinic Aciduria in Urea Cycle Disorders	1/11	0.04630715680061324	0.2601297229488897	0	0	23.416470588235295	71.94614007723759	GOT2
Citrullinemia Type I	1/11	0.04630715680061324	0.2601297229488897	0	0	23.416470588235295	71.94614007723759	GOT2
Citrullinemia Type II	1/11	0.04630715680061324	0.2601297229488897	0	0	23.416470588235295	71.94614007723759	GOT2
Hexosamine Pathway in Diabetic Microangiopathy	1/11	0.04630715680061324	0.2601297229488897	0	0	23.416470588235295	71.94614007723759	PLAU
WNT Canonical Signaling in Mantle Cell Lymphoma	1/11	0.04630715680061324	0.2601297229488897	0	0	23.416470588235295	71.94614007723759	MYC
Hyperammonemia Type I	1/11	0.04630715680061324	0.2601297229488897	0	0	23.416470588235295	71.94614007723759	GOT2
Hyperammonemia Type II	1/11	0.04630715680061324	0.2601297229488897	0	0	23.416470588235295	71.94614007723759	GOT2
IL6/JAK/STAT3 Signaling in Cholesteatoma	1/11	0.04630715680061324	0.2601297229488897	0	0	23.416470588235295	71.94614007723759	MYC
Telomeric Proteins/NFKB Positive Feedback Interplay in Cancer	1/12	0.05041028257884421	0.2601297229488897	0	0	21.28663101604278	63.595089599609956	MYC
Argininemia	1/13	0.05449596012786739	0.2601297229488897	0	0	19.511764705882353	56.77199069596926	GOT2
Osteoblast Dysfunction in Hypoparathyroidism	1/13	0.05449596012786739	0.2601297229488897	0	0	19.511764705882353	56.77199069596926	MYC
CC Chemokine Receptor Signaling	2/88	0.055149635059429845	0.2601297229488897	0	0	5.489479512735326	15.906893057840291	GNA14;PTK2B
Hypertrophic Cardiomyopathy	2/89	0.056263866722923495	0.2601297229488897	0	0	5.426108374384237	15.614726984034691	TIMP2;PTK2B
Mast-Cells De Novo Synthesized Mediators via IgE Independent Signaling	2/90	0.05738600604296518	0.2601297229488897	0	0	5.364177489177489	15.330576816876379	GNA14;PLAU
Proteins Involved in Urolithiasis	1/14	0.05856426270354889	0.2601297229488897	0	0	18.00995475113122	51.10559906499446	PLAU
PRL and CSH Action in Mammary Gland	1/14	0.05856426270354889	0.2601297229488897	0	0	18.00995475113122	51.10559906499446	MYC
NOTCH Signaling in Multiple Myeloma	1/14	0.05856426270354889	0.2601297229488897	0	0	18.00995475113122	51.10559906499446	MYC
Proteins Involved in Astrocytoma	2/92	0.05965366104364009	0.2601297229488897	0	0	5.2444444444444445	14.785136502876078	MYC;TIMP2
B-Cell Chronic Lymphocytic Leukemia	2/94	0.061951912727547895	0.2601297229488897	0	0	5.12991718426501	14.268335220264353	MYC;PTK2B
NCAM1 -> CREB/ELK/SRF/MYC Signaling	1/15	0.06261526327259834	0.2601297229488897	0	0	16.722689075630253	46.33432734971711	MYC
WNT Signaling Dysregulation in Osteoblast	1/15	0.06261526327259834	0.2601297229488897	0	0	16.722689075630253	46.33432734971711	MYC
WNT Signaling in Hepatocellular Carcinoma	1/15	0.06261526327259834	0.2601297229488897	0	0	16.722689075630253	46.33432734971711	MYC
Vitamin D Represses Transcription	1/15	0.06261526327259834	0.2601297229488897	0	0	16.722689075630253	46.33432734971711	CYP27B1
ADAM33 Role in Asthma	1/15	0.06261526327259834	0.2601297229488897	0	0	16.722689075630253	46.33432734971711	TIMP2
Follicular Lymphoma	2/97	0.06545517817555309	0.2601297229488897	0	0	4.967167919799499	13.542435321821051	MYC;PTK2B
Proteins Involved in Neuroblastoma	3/216	0.06629186064790582	0.2601297229488897	0	0	3.3431189546920073	9.072182307496025	IGFBP5;MYC;STC2
MacrophageR -> CEBPB -> NF-kB Signaling	1/16	0.06664903451940749	0.2601297229488897	0	0	15.607058823529412	42.26882712102443	PTK2B
Tamoxifen Induced Endometrial Cancer	1/16	0.06664903451940749	0.2601297229488897	0	0	15.607058823529412	42.26882712102443	MYC
Proteins Involved in Follicular Lymphoma	1/17	0.0706656488135395	0.2601297229488897	0	0	14.630882352941176	38.768849097220134	MYC
NTRK1/2/3 -> Acetylcholine Production	1/17	0.0706656488135395	0.2601297229488897	0	0	14.630882352941176	38.768849097220134	PTK2B
Hyperparathyroidism, Neonatal Severe	1/17	0.0706656488135395	0.2601297229488897	0	0	14.630882352941176	38.768849097220134	PTK2B
Leptin Role in Endometriosis	1/17	0.0706656488135395	0.2601297229488897	0	0	14.630882352941176	38.768849097220134	MYC
Proteins with Altered Expression in Tumor-Promoting Inflammation	1/17	0.0706656488135395	0.2601297229488897	0	0	14.630882352941176	38.768849097220134	MYC
T-Cell Acute Lymphoblastic Leukemia	2/103	0.07265471088543778	0.2601297229488897	0	0	4.670674210278171	12.246680816138321	MYC;PTK2B
FOXA2 Signaling in Prostate Cancer	1/18	0.07466517827093744	0.2601297229488897	0	0	13.76955017301038	35.728422579909434	EGLN3
Retinal Ganglion and Suprachiasmatic Nucleus in Melatonin Synthesis Regulation	1/18	0.07466517827093744	0.2601297229488897	0	0	13.76955017301038	35.728422579909434	MYC
Wolfram Syndrome Progression (Hypothesis)	1/18	0.07466517827093744	0.2601297229488897	0	0	13.76955017301038	35.728422579909434	EDEM2
Alternative Lengthening of Telomeres in Cancer	1/18	0.07466517827093744	0.2601297229488897	0	0	13.76955017301038	35.728422579909434	MYC
Macrophage Survival through CCR5 and CXCR4 Mediated Signaling	1/18	0.07466517827093744	0.2601297229488897	0	0	13.76955017301038	35.728422579909434	PTK2B
Extracellular Matrix Turnover	1/18	0.07466517827093744	0.2601297229488897	0	0	13.76955017301038	35.728422579909434	TIMP2
Sister Chromatid Cohesion	1/18	0.07466517827093744	0.2601297229488897	0	0	13.76955017301038	35.728422579909434	NIPBL
B-Cell Receptor -> NFATC Signaling	1/18	0.07466517827093744	0.2601297229488897	0	0	13.76955017301038	35.728422579909434	NFATC3
Proteins with Altered Expression in Cancer Metastases	2/106	0.07634661360145581	0.2601297229488897	0	0	4.535256410256411	11.666818322795093	PLAU;MYC
Glutamate Overdose and Aura Effect in Familial Hemiplegic Migraine Type 3	1/19	0.07864769465120389	0.2601297229488897	0	0	13.003921568627451	33.06607217254294	KCNMA1
Glutamate Overdose and Aura Effect in Migraine Type 2	1/19	0.07864769465120389	0.2601297229488897	0	0	13.003921568627451	33.06607217254294	KCNMA1
Ions Reabsorption Dysregulation in Nephrolithiasis	1/19	0.07864769465120389	0.2601297229488897	0	0	13.003921568627451	33.06607217254294	CYP27B1
Genes with Mutations in Cancer Metabolic Reprogramming	1/19	0.07864769465120389	0.2601297229488897	0	0	13.003921568627451	33.06607217254294	MYC
Proteins with Altered Expression in Cancer-Associated Enabling of Replicative Immortality	1/19	0.07864769465120389	0.2601297229488897	0	0	13.003921568627451	33.06607217254294	MYC
BMP2 and Canonical WNT Signaling in Pulmonary Artery Endothelial Cells	1/20	0.08261326946777713	0.2601297229488897	0	0	12.318885448916408	30.718187529247054	MYC
IL2R -> ELK/SRF/MYC Signaling	1/20	0.08261326946777713	0.2601297229488897	0	0	12.318885448916408	30.718187529247054	MYC
Hypoparathyroidism, Primary	1/20	0.08261326946777713	0.2601297229488897	0	0	12.318885448916408	30.718187529247054	PTK2B
Apoptosis Block by Inhibitor of Apoptosis Proteins (IAPs) in Cancer	1/20	0.08261326946777713	0.2601297229488897	0	0	12.318885448916408	30.718187529247054	ARHGEF3
SCF/FBXW7 Complex	1/20	0.08261326946777713	0.2601297229488897	0	0	12.318885448916408	30.718187529247054	MYC
Potassium Cycling in the Inner Ear (Noise-Induced)	1/21	0.08656197393564473	0.2601297229488897	0	0	11.702352941176471	28.634424919991112	KCNMA1
IGF1R -> ELK/SRF/HIF1A/MYC/SREBF Signaling	1/21	0.08656197393564473	0.2601297229488897	0	0	11.702352941176471	28.634424919991112	MYC
CCL2 Role in CGRP Expression and Release	1/21	0.08656197393564473	0.2601297229488897	0	0	11.702352941176471	28.634424919991112	GNA14
KIT -> MITF Signaling	1/21	0.08656197393564473	0.2601297229488897	0	0	11.702352941176471	28.634424919991112	PTK2B
RET1 Mutation in Hyperparathyroidism	1/21	0.08656197393564473	0.2601297229488897	0	0	11.702352941176471	28.634424919991112	MYC
Glutamate Overdose and Aura Effect in Migraine Type 1	1/21	0.08656197393564473	0.2601297229488897	0	0	11.702352941176471	28.634424919991112	KCNMA1
TRPM7/8 in Pancreatic Adenocarcinoma	1/21	0.08656197393564473	0.2601297229488897	0	0	11.702352941176471	28.634424919991112	MYC
ADRA1 -> Prostaglandin Generation	1/22	0.0904938789441273	0.2601297229488897	0	0	11.14453781512605	26.774451939878727	KCNMA1
TNFR/NF-kB Alternative Pathway in Multiple Myeloma Plasma Cells	1/22	0.0904938789441273	0.2601297229488897	0	0	11.14453781512605	26.774451939878727	MYC
HPV E6 and E7 Induced Block of Apoptosis in Keratinocytes	1/22	0.0904938789441273	0.2601297229488897	0	0	11.14453781512605	26.774451939878727	MYC
Telomere Maintenance	1/22	0.0904938789441273	0.2601297229488897	0	0	11.14453781512605	26.774451939878727	TEP1
Advanced Glycation End Products Pathway in Diabetic Microangiopathy	1/22	0.0904938789441273	0.2601297229488897	0	0	11.14453781512605	26.774451939878727	PLAU
Potassium Cycling in the Inner Ear (Age-Related)	1/22	0.0904938789441273	0.2601297229488897	0	0	11.14453781512605	26.774451939878727	KCNMA1
beta-Catenin/Androgen Receptor Signaling in Prostate Cancer	1/23	0.0944090551290999	0.2601297229488897	0	0	10.637433155080213	25.105600520866265	MYC
Bone Resorption in Hyperparathyroidism	1/23	0.0944090551290999	0.2601297229488897	0	0	10.637433155080213	25.105600520866265	MYC
UrokinaseR -> ELK/SRF Signaling	1/23	0.0944090551290999	0.2601297229488897	0	0	10.637433155080213	25.105600520866265	PLAU
Telogen Maintenance in Androgenic Alopecia	1/23	0.0944090551290999	0.2601297229488897	0	0	10.637433155080213	25.105600520866265	MYC
Scavenger Receptors in Platelet Activation	1/23	0.0944090551290999	0.2601297229488897	0	0	10.637433155080213	25.105600520866265	YES1
Werner Syndrome (Adult Progeria)	1/23	0.0944090551290999	0.2601297229488897	0	0	10.637433155080213	25.105600520866265	TEP1
TERT/WNT Activation in Cancer	1/23	0.0944090551290999	0.2601297229488897	0	0	10.637433155080213	25.105600520866265	MYC
Multiple Myeloma	2/121	0.09564412981322423	0.2601297229488897	0	0	3.9605842336934773	9.295970254918984	MYC;PTK2B
Proteins Involved in Endometriosis	3/256	0.09817483623320744	0.2601297229488897	0	0	2.8088480403828755	6.5193513196009905	DUSP2;MYC;TIMP2
Proteins Involved in Congenital Deafness	1/24	0.09830757280729437	0.2601297229488897	0	0	10.174424552429668	23.601146819428006	KCNMA1
HIF1 Signaling	1/24	0.09830757280729437	0.2601297229488897	0	0	10.174424552429668	23.601146819428006	EGLN3
Proteins Involved in Hypoxia-Induced Pulmonary Hypertension	1/24	0.09830757280729437	0.2601297229488897	0	0	10.174424552429668	23.601146819428006	NFATC3
Lactate as a Signaling Molecule in Cancer Cells	1/24	0.09830757280729437	0.2601297229488897	0	0	10.174424552429668	23.601146819428006	MYC
Mutations in Krebs Cycle Enzymes in Cancer	1/24	0.09830757280729437	0.2601297229488897	0	0	10.174424552429668	23.601146819428006	EGLN3
NOTCH Signaling in Hepatocellular Carcinoma	1/24	0.09830757280729437	0.2601297229488897	0	0	10.174424552429668	23.601146819428006	MYC
ALK Associated Neuroblastoma	1/24	0.09830757280729437	0.2601297229488897	0	0	10.174424552429668	23.601146819428006	MYC
Potassium Cycling in the Inner Ear (Congenital Deafness)	1/24	0.09830757280729437	0.2601297229488897	0	0	10.174424552429668	23.601146819428006	KCNMA1
CD8+ T-Cell Response to Self-Determinants in Diabetes	1/25	0.10218950202672386	0.2601297229488897	0	0	9.75	22.23903168224061	PTK2B
Eat me Signal: Apoptotic Cell Initiates Phagocytosis	1/25	0.10218950202672386	0.2601297229488897	0	0	9.75	22.23903168224061	XKR8
Sialophorin -> CTNNB/MYC/TP53 Signaling	1/25	0.10218950202672386	0.2601297229488897	0	0	9.75	22.23903168224061	MYC
SERPINA1 Associated Liver Damage	1/25	0.10218950202672386	0.2601297229488897	0	0	9.75	22.23903168224061	EDEM2
MTOR/TORC in Cancer Cell Motility and Invasion	1/25	0.10218950202672386	0.2601297229488897	0	0	9.75	22.23903168224061	PLAU
Myeloid Cell Differentiation Block in Leukemia	1/25	0.10218950202672386	0.2601297229488897	0	0	9.75	22.23903168224061	MYC
CD38 -> cADPR/Calcium Signaling	1/25	0.10218950202672386	0.2601297229488897	0	0	9.75	22.23903168224061	PTK2B
T-Cell Receptor -> NFATC Signaling	1/26	0.10605491252536185	0.2601297229488897	0	0	9.359529411764706	21.000895961244385	NFATC3
Endothelial Cell Dysfunction in Progressive Diabetic Nephropathy	1/26	0.10605491252536185	0.2601297229488897	0	0	9.359529411764706	21.000895961244385	MYC
Glutamate Overdose and Aura Effect Caused by Mutations in PRRT2 Gene	1/26	0.10605491252536185	0.2601297229488897	0	0	9.359529411764706	21.000895961244385	KCNMA1
Microglia and Motor Neuron Interaction Dysregulation	1/26	0.10605491252536185	0.2601297229488897	0	0	9.359529411764706	21.000895961244385	PTK2B
ROS and RNS in Vasoconstriction and Vasodilation Regulation	1/26	0.10605491252536185	0.2601297229488897	0	0	9.359529411764706	21.000895961244385	PTK2B
Nitric Oxide Effects on beta-Cell	1/26	0.10605491252536185	0.2601297229488897	0	0	9.359529411764706	21.000895961244385	EDEM2
CD157/ITGB2 Signaling in Myeloid Cell	1/26	0.10605491252536185	0.2601297229488897	0	0	9.359529411764706	21.000895961244385	PTK2B
Glutamate Overdose and Aura Effect Caused by Mutations in SLC1A3 Gene	1/27	0.1099038737594078	0.2601297229488897	0	0	8.999095022624434	19.871344206358376	KCNMA1
Glutamate Overdose and Aura Effect Overiew	1/27	0.1099038737594078	0.2601297229488897	0	0	8.999095022624434	19.871344206358376	KCNMA1
Inherited Channelopathies	1/27	0.1099038737594078	0.2601297229488897	0	0	8.999095022624434	19.871344206358376	KCNMA1
WNT Canonical Signaling Activation in Cancer	1/27	0.1099038737594078	0.2601297229488897	0	0	8.999095022624434	19.871344206358376	MYC
EGFR -> NCOR2 Signaling	1/28	0.11373645491494558	0.2601297229488897	0	0	8.665359477124182	18.837376322734553	PTK2B
BMP/TGF-beta Signaling Impairment in Pulmonary Hypertension	1/28	0.11373645491494558	0.2601297229488897	0	0	8.665359477124182	18.837376322734553	MYC
Hyperglycemia and Hyperlipidemia Trigger beta-Cell Apoptosis	1/28	0.11373645491494558	0.2601297229488897	0	0	8.665359477124182	18.837376322734553	EDEM2
MYOC Associated Glaucoma	1/28	0.11373645491494558	0.2601297229488897	0	0	8.665359477124182	18.837376322734553	EDEM2
Postsynaptic Neuron Activation	1/28	0.11373645491494558	0.2601297229488897	0	0	8.665359477124182	18.837376322734553	KCNMA1
Apoptosis of Melanocyte in Vitiligo	1/29	0.117552724870697	0.2601297229488897	0	0	8.35546218487395	17.887944321802927	PTK2B
CHRM1 -> IL2 Production	1/29	0.117552724870697	0.2601297229488897	0	0	8.35546218487395	17.887944321802927	PTK2B
Dystrophin Glycoprotein Complex Signaling in Muscular Dystrophies	1/29	0.117552724870697	0.2601297229488897	0	0	8.35546218487395	17.887944321802927	PTK2B
RARA Signaling in Acute Myeloid Leukemia (M3)	1/29	0.117552724870697	0.2601297229488897	0	0	8.35546218487395	17.887944321802927	MYC
SPP1 Induced Survival of Myelin Specific T-Cells in Multiple Sclerosis	1/29	0.117552724870697	0.2601297229488897	0	0	8.35546218487395	17.887944321802927	PTK2B
Macrophage Function in Diabetes Mellitus Type 1	1/29	0.117552724870697	0.2601297229488897	0	0	8.35546218487395	17.887944321802927	PTK2B
NOTCH Signaling Deregulation in Cancer	1/29	0.117552724870697	0.2601297229488897	0	0	8.35546218487395	17.887944321802927	MYC
RAS/RAF/MAPK Signaling Activation in Cancer	1/29	0.117552724870697	0.2601297229488897	0	0	8.35546218487395	17.887944321802927	MYC
Proteins Involved in Cystic Kidney Disease	1/30	0.12135275220631468	0.2601297229488897	0	0	8.066937119675456	17.0136033150249	MYC
CD8+ T-Cell Action Impairment in HIV Type 1 Infection	1/30	0.12135275220631468	0.2601297229488897	0	0	8.066937119675456	17.0136033150249	PTK2B
CFTR Misfolding and Degradation (Class II Mutations)	1/30	0.12135275220631468	0.2601297229488897	0	0	8.066937119675456	17.0136033150249	EDEM2
RAGE/AGER and S100 Proteins in Cardiovascular Injury	1/30	0.12135275220631468	0.2601297229488897	0	0	8.066937119675456	17.0136033150249	PLAU
Thyroid Hormones in Adipose Tissue Metabolism	1/30	0.12135275220631468	0.2601297229488897	0	0	8.066937119675456	17.0136033150249	ME1
TNFR/NF-kB Classical Pathway in Multiple Myeloma Plasma Cells	1/30	0.12135275220631468	0.2601297229488897	0	0	8.066937119675456	17.0136033150249	MYC
Thrombopoietin Receptors Signaling in Platelet Maturation	1/30	0.12135275220631468	0.2601297229488897	0	0	8.066937119675456	17.0136033150249	MYC
Adherens Junction Assembly (Cadherins)	1/30	0.12135275220631468	0.2601297229488897	0	0	8.066937119675456	17.0136033150249	YES1
Mast-Cell Related Chemokines Signaling in Asthma	1/30	0.12135275220631468	0.2601297229488897	0	0	8.066937119675456	17.0136033150249	GNA14
Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway	1/31	0.12513660526532908	0.2601297229488897	0	0	7.79764705882353	16.206234277302418	MYC
Vascular Endothelial Cell Activation by NO	1/31	0.12513660526532908	0.2601297229488897	0	0	7.79764705882353	16.206234277302418	PLAU
ER Stress (Unfolded Protein Response)	1/31	0.12513660526532908	0.2601297229488897	0	0	7.79764705882353	16.206234277302418	EDEM2
AngiopoietinR -> AP-1 Signaling	1/31	0.12513660526532908	0.2601297229488897	0	0	7.79764705882353	16.206234277302418	PTK2B
CD38/CD3 -> JUN/FOS/NF-kB Signaling in T-cell Proliferation	1/31	0.12513660526532908	0.2601297229488897	0	0	7.79764705882353	16.206234277302418	PTK2B
Estrogens/ESR1 non-Genomic Signaling	1/32	0.12890435205333023	0.2601297229488897	0	0	7.54573055028463	15.458822023817966	PTK2B
IGF1R -> MEF/MYOD/MYOG Signaling	1/32	0.12890435205333023	0.2601297229488897	0	0	7.54573055028463	15.458822023817966	PTK2B
Insulin Influence on Protein Synthesis	1/32	0.12890435205333023	0.2601297229488897	0	0	7.54573055028463	15.458822023817966	MYC
Hereditary Breast and Ovarian Cancer Syndrome	1/32	0.12890435205333023	0.2601297229488897	0	0	7.54573055028463	15.458822023817966	MYC
ROS in Triggering Vascular Inflammation	1/32	0.12890435205333023	0.2601297229488897	0	0	7.54573055028463	15.458822023817966	PLAU
non-Hereditary Genetic Rearrangements in Neuroblastoma	1/32	0.12890435205333023	0.2601297229488897	0	0	7.54573055028463	15.458822023817966	MYC
Melanoma	2/145	0.12895949437976117	0.2601297229488897	0	0	3.291874791874792	6.742605325470232	PLAU;MYC
Proteins Involved in Breast Cancer Related to WNT Signaling Pathway	1/34	0.1363917975983422	0.2686080236923709	0	0	7.0877005347593585	14.12028477327799	MYC
Proteins Involved in Gout	1/34	0.1363917975983422	0.2686080236923709	0	0	7.0877005347593585	14.12028477327799	PLAU
CCR5 Signaling in Macrophages	1/34	0.1363917975983422	0.2686080236923709	0	0	7.0877005347593585	14.12028477327799	PTK2B
G1/S Phase Transition	1/34	0.1363917975983422	0.2686080236923709	0	0	7.0877005347593585	14.12028477327799	MYC
Preconditioning Ischemia	1/35	0.14011163097102505	0.2686080236923709	0	0	6.8788927335640135	13.519196644704605	PTK2B
WNT Signaling in Breast Cancer	1/35	0.14011163097102505	0.2686080236923709	0	0	6.8788927335640135	13.519196644704605	MYC
N2 Neutrophils in Tumor-Promoting Inflammation and Tumor Progression	1/35	0.14011163097102505	0.2686080236923709	0	0	6.8788927335640135	13.519196644704605	MYC
NOTCH1 Signaling in Breast Cancer	1/35	0.14011163097102505	0.2686080236923709	0	0	6.8788927335640135	13.519196644704605	MYC
JNK/MAPK Signaling	1/36	0.14381562741602863	0.2686080236923709	0	0	6.6820168067226895	12.957921780117758	NFATC3
Donohue Syndrome Progression (Hypothesis)	1/36	0.14381562741602863	0.2686080236923709	0	0	6.6820168067226895	12.957921780117758	MYC
Lipoxin A4/FPR2-Related Neutrophil Depression	1/36	0.14381562741602863	0.2686080236923709	0	0	6.6820168067226895	12.957921780117758	TIMP2
Hyperparathyroidism, Secondary Effect	1/36	0.14381562741602863	0.2686080236923709	0	0	6.6820168067226895	12.957921780117758	MYC
EPCAM in Cancer Cell Motility and Proliferation	1/36	0.14381562741602863	0.2686080236923709	0	0	6.6820168067226895	12.957921780117758	MYC
WNT Signaling Activation by Blocking of Tumor Suppressors	1/36	0.14381562741602863	0.2686080236923709	0	0	6.6820168067226895	12.957921780117758	MYC
ERK5/MAPK7 Signaling	1/37	0.1475038535361489	0.2695079816018633	0	0	6.496078431372549	12.432850862154837	MYC
Proteins Involved in Cholesteatoma	1/37	0.1475038535361489	0.2695079816018633	0	0	6.496078431372549	12.432850862154837	MYC
TERT Activation in Cancer	1/37	0.1475038535361489	0.2695079816018633	0	0	6.496078431372549	12.432850862154837	MYC
Bradykinin Effects in Inflammation	1/39	0.1548332599823739	0.2695079816018633	0	0	6.1535603715170275	11.47889141140809	PLAU
Hair Follicle Keratinocyte Apoptosis	1/39	0.1548332599823739	0.2695079816018633	0	0	6.1535603715170275	11.47889141140809	MYC
VEGFA in Neovascular Glaucoma	1/39	0.1548332599823739	0.2695079816018633	0	0	6.1535603715170275	11.47889141140809	MYC
Inhibition of THBS1 Activates Angiogenesis in Cancer	1/39	0.1548332599823739	0.2695079816018633	0	0	6.1535603715170275	11.47889141140809	MYC
Apoptosis Block in Melanoma Cell	1/39	0.1548332599823739	0.2695079816018633	0	0	6.1535603715170275	11.47889141140809	MYC
CD38/CD19 -> JUN/FOS/NF-kB Signaling in B-cell Proliferation	1/39	0.1548332599823739	0.2695079816018633	0	0	6.1535603715170275	11.47889141140809	PTK2B
Proteins Involved in Pulmonary Hypertension	2/165	0.1584636726217504	0.2695079816018633	0	0	2.8850423605024833	5.3149113187565655	PLAU;NFATC3
Proteins Involved in Osteopetrosis	1/40	0.15847457220368777	0.2695079816018633	0	0	5.995475113122172	11.044631186923048	PTK2B
Proteins Involved in T-Cell Acute Lymphoblastic Leukemia	1/40	0.15847457220368777	0.2695079816018633	0	0	5.995475113122172	11.044631186923048	MYC
SIRT1 Signaling in Aging	1/40	0.15847457220368777	0.2695079816018633	0	0	5.995475113122172	11.044631186923048	MYC
Interstitial Fibroblasts in Pyelonephritis	1/40	0.15847457220368777	0.2695079816018633	0	0	5.995475113122172	11.044631186923048	MYC
Glycolysis Activation in Cancer (Warburg Effect)	1/40	0.15847457220368777	0.2695079816018633	0	0	5.995475113122172	11.044631186923048	MYC
Astrocytoma	1/41	0.1621003778502616	0.2695079816018633	0	0	5.845294117647059	10.635743648833243	MYC
EGFR/ERBB2 -> TP53 Signaling	1/41	0.1621003778502616	0.2695079816018633	0	0	5.845294117647059	10.635743648833243	PTK2B
RAS/RAF/MAPK Signaling Activation by Blocking of Tumor Suppressors	1/41	0.1621003778502616	0.2695079816018633	0	0	5.845294117647059	10.635743648833243	MYC
EGFR -> AP-1/ATF2 Signaling	1/42	0.16571074221421955	0.2695079816018633	0	0	5.702439024390244	10.250199880384558	PTK2B
Cowden Syndrome	1/42	0.16571074221421955	0.2695079816018633	0	0	5.702439024390244	10.250199880384558	MYC
HIF1A in Vasculogenic Mimicry of Cancer	1/42	0.16571074221421955	0.2695079816018633	0	0	5.702439024390244	10.250199880384558	PLAU
Osteoclast Activation in Postmenopause	1/42	0.16571074221421955	0.2695079816018633	0	0	5.702439024390244	10.250199880384558	PTK2B
Proteins Involved in Mucinous Ovarian Carcinoma	1/43	0.16930573029517199	0.2695079816018633	0	0	5.5663865546218485	9.886176072320994	MYC
Ependymoma	1/43	0.16930573029517199	0.2695079816018633	0	0	5.5663865546218485	9.886176072320994	MYC
IgE Induces Airway Smooth Muscle Cell Proliferation	1/43	0.16930573029517199	0.2695079816018633	0	0	5.5663865546218485	9.886176072320994	PTK2B
IGF1R/AKT Signaling in Breast Cancer	1/43	0.16930573029517199	0.2695079816018633	0	0	5.5663865546218485	9.886176072320994	MYC
MicroRNAs Role in Melanoma	1/43	0.16930573029517199	0.2695079816018633	0	0	5.5663865546218485	9.886176072320994	MYC
beta-Cell Mass Regulation	1/44	0.17288540678205494	0.2695079816018633	0	0	5.436662106703146	9.54202860693275	MYC
Eosinophil Activation and Degranulation in Asthma	1/44	0.17288540678205494	0.2695079816018633	0	0	5.436662106703146	9.54202860693275	GNA14
HIF1A as Master Regulator of Angiogenesis in Cancer	1/44	0.17288540678205494	0.2695079816018633	0	0	5.436662106703146	9.54202860693275	EGLN3
Adipokines Production by Adipocyte Impaired in Obesity	1/44	0.17288540678205494	0.2695079816018633	0	0	5.436662106703146	9.54202860693275	MYC
Adiponectin Synthesis Declines in Insulin Resistance	1/44	0.17288540678205494	0.2695079816018633	0	0	5.436662106703146	9.54202860693275	MYC
Treg Cells Promote Immunosuppression in Cancer Immune Escape	1/44	0.17288540678205494	0.2695079816018633	0	0	5.436662106703146	9.54202860693275	PTK2B
Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling	2/175	0.17365731665073417	0.2695079816018633	0	0	2.7169006330856043	4.756400143179643	PLAU;MYC
Splenic Marginal Zone Lymphoma	1/45	0.17644983614692364	0.2695079816018633	0	0	5.31283422459893	9.216272653459013	MYC
Adipokines Production by Adipocyte	1/46	0.17999908252900587	0.2695079816018633	0	0	5.1945098039215685	8.907563723274029	MYC
Proteins Involved in Clear Cell Ovarian Carcinoma	1/46	0.17999908252900587	0.2695079816018633	0	0	5.1945098039215685	8.907563723274029	MYC
Proteins with Altered Expression in Melanoma	1/46	0.17999908252900587	0.2695079816018633	0	0	5.1945098039215685	8.907563723274029	PLAU
Natural Killer Cell Activation through Integrins and non-ITAM-Containing Receptors	1/46	0.17999908252900587	0.2695079816018633	0	0	5.1945098039215685	8.907563723274029	PTK2B
Suppression of Caspase Activity in Cancer	1/46	0.17999908252900587	0.2695079816018633	0	0	5.1945098039215685	8.907563723274029	ARHGEF3
Peripheral Tissue Microangiopathy	1/46	0.17999908252900587	0.2695079816018633	0	0	5.1945098039215685	8.907563723274029	PLAU
FibronectinR -> AP-1/ELK/SRF/SREBF Signaling	1/47	0.1835332098896196	0.2695079816018633	0	0	5.081329923273657	8.61468170774335	PTK2B
IL1B Expression Targets -> Nociception	1/47	0.1835332098896196	0.2695079816018633	0	0	5.081329923273657	8.61468170774335	PLAU
TGFBR Signaling in Pancreatic Neoplasms	1/47	0.1835332098896196	0.2695079816018633	0	0	5.081329923273657	8.61468170774335	MYC
Tubular Cell Dysfunction in Progressive Diabetic Nephropathy	1/47	0.1835332098896196	0.2695079816018633	0	0	5.081329923273657	8.61468170774335	MYC
BSG (CD147) in Cancer Cells Motility, Invasion and Survival	1/47	0.1835332098896196	0.2695079816018633	0	0	5.081329923273657	8.61468170774335	MYC
IL6/IGF1/VEGFA Signaling in Multiple Myeloma	1/47	0.1835332098896196	0.2695079816018633	0	0	5.081329923273657	8.61468170774335	MYC
Osteoclast Activation in Psoriatic Arthritis	1/47	0.1835332098896196	0.2695079816018633	0	0	5.081329923273657	8.61468170774335	PTK2B
EGFR/ERBB3 -> MEF/MYOD/NFATC/MYOG Signaling	1/48	0.1870522818483187	0.2695079816018633	0	0	4.9729662077597	8.336517035216884	PTK2B
Bone Loss in Osteoporosis	1/48	0.1870522818483187	0.2695079816018633	0	0	4.9729662077597	8.336517035216884	MYC
Proteins Involved in Endometrioid Ovarian Carcinoma	1/48	0.1870522818483187	0.2695079816018633	0	0	4.9729662077597	8.336517035216884	MYC
Proteins Involved in Low-Grade Serous Ovarian Carcinoma	1/48	0.1870522818483187	0.2695079816018633	0	0	4.9729662077597	8.336517035216884	MYC
mTOR Signaling Activation by Amino Acids	1/48	0.1870522818483187	0.2695079816018633	0	0	4.9729662077597	8.336517035216884	GOT2
T-Cell Cytotoxic Response in Ulcerative Colitis	1/48	0.1870522818483187	0.2695079816018633	0	0	4.9729662077597	8.336517035216884	PTK2B
Glioblastoma, Primary	1/48	0.1870522818483187	0.2695079816018633	0	0	4.9729662077597	8.336517035216884	MYC
Proteins with Altered Expression in Cancer Immune Escape	1/48	0.1870522818483187	0.2695079816018633	0	0	4.9729662077597	8.336517035216884	VTCN1
Proteins Involved in Systemic Scleroderma	1/49	0.19055636178365606	0.2701461675085566	0	0	4.8691176470588236	8.072058613293224	TIMP2
CDH2 Activation Promotes Cancer Cell Migration and Survival	1/49	0.19055636178365606	0.2701461675085566	0	0	4.8691176470588236	8.072058613293224	PTK2B
mTOR/NF-kB/BCR Signaling Disregulation in Mantle Cell Lymphoma	1/49	0.19055636178365606	0.2701461675085566	0	0	4.8691176470588236	8.072058613293224	MYC
Polycystins Mutation Effects in Cystic Kidney Disease	1/49	0.19055636178365606	0.2701461675085566	0	0	4.8691176470588236	8.072058613293224	MYC
Proteins Involved in Endometrial Cancer	1/50	0.19404551285483848	0.2718177223720555	0	0	4.769507803121249	7.820383303288144	MYC
Synovial Fibroblast Activation in Psoriatic Arthritis	1/50	0.19404551285483848	0.2718177223720555	0	0	4.769507803121249	7.820383303288144	MYC
Glioblastoma, Secondary	1/50	0.19404551285483848	0.2718177223720555	0	0	4.769507803121249	7.820383303288144	MYC
ESR1 Signaling in Breast Cancer	1/51	0.19751979786874949	0.27286802173840996	0	0	4.673882352941177	7.580646707679503	MYC
Synovial Fibroblast Activation by Citokines in Rheumatoid Arthritis	1/51	0.19751979786874949	0.27286802173840996	0	0	4.673882352941177	7.580646707679503	MYC
ROS in Angiotensin Mediated Cardiovascular Remodeling and Hypertrophy	1/51	0.19751979786874949	0.27286802173840996	0	0	4.673882352941177	7.580646707679503	PTK2B
EGFR Signaling	1/52	0.20097927946738411	0.27286802173840996	0	0	4.582006920415225	7.3520750737676215	MYC
Myeloid Derived Suppressor Cells in Cancer Immune Escape	1/52	0.20097927946738411	0.27286802173840996	0	0	4.582006920415225	7.3520750737676215	MYC
Acute Cytotoxic CD8+T-Cell Response against Melanocytes	1/52	0.20097927946738411	0.27286802173840996	0	0	4.582006920415225	7.3520750737676215	PTK2B
VEGF Independent Angiogenesis in Cancer	1/52	0.20097927946738411	0.27286802173840996	0	0	4.582006920415225	7.3520750737676215	MYC
Peutz-Jeghers Syndrome	1/52	0.20097927946738411	0.27286802173840996	0	0	4.582006920415225	7.3520750737676215	MYC
Insulin Signaling	1/54	0.20785408138648875	0.28004767453981116	0	0	4.40865704772475	6.92564302052444	MYC
ERBB/VEGFR/Akt Signaling in Breast Cancer	1/54	0.20785408138648875	0.28004767453981116	0	0	4.40865704772475	6.92564302052444	MYC
Hepatic Stellate Cells in non-Alcoholic Fatty Liver Disease	1/55	0.2112695256357926	0.2835670819370144	0	0	4.326797385620915	6.726528295665297	PLAU
Proteins Involved in B-Cell Chronic Lymphocytic Leukemia	1/56	0.21467041423781064	0.2850890866219617	0	0	4.247914438502674	6.536059430207652	MYC
Neutrophil Chemotaxis	1/56	0.21467041423781064	0.2850890866219617	0	0	4.247914438502674	6.536059430207652	GNA14
Proteins Involved in High-Grade Serous Ovarian Carcinoma	1/57	0.21805680846438996	0.2850890866219617	0	0	4.171848739495799	6.353724215387732	MYC
Genes with Mutations Associated with Retinitis Pigmentosa	1/57	0.21805680846438996	0.2850890866219617	0	0	4.171848739495799	6.353724215387732	NRL
Synovial Fibroblast Proliferation in Rheumatoid Arthritis	1/57	0.21805680846438996	0.2850890866219617	0	0	4.171848739495799	6.353724215387732	MYC
HPV E6 and E7 Induced Disruption of TNFR/NF-kB Signaling in Keratinocytes	1/57	0.21805680846438996	0.2850890866219617	0	0	4.171848739495799	6.353724215387732	MYC
Osteoclast Activation in Rheumatoid Arthritis	1/57	0.21805680846438996	0.2850890866219617	0	0	4.171848739495799	6.353724215387732	PTK2B
Peripheral T-Cell Tolerance	1/58	0.22142876941668724	0.28736895442680366	0	0	4.098452012383901	6.179048898114302	PTK2B
Osteoclast Activation in Gout	1/58	0.22142876941668724	0.28736895442680366	0	0	4.098452012383901	6.179048898114302	PTK2B
Proteins Involved in Hearing Loss	2/209	0.22675322900203948	0.2928354943078388	0	0	2.266735679779158	3.3635930941177485	KCNMA1;DUSP6
Proteins Involved in Multiple Myeloma	1/60	0.22812963437579506	0.2928354943078388	0	0	3.9591226321036888	5.850954699068187	MYC
Mucinous Ovarian Carcinoma	1/60	0.22812963437579506	0.2928354943078388	0	0	3.9591226321036888	5.850954699068187	MYC
Proteins Involved in Diffuse Large-B-Cell Lymphoma	1/61	0.23145865919344172	0.2960322706350903	0	0	3.8929411764705883	5.696751040020639	MYC
CD8+ T-Cell Activation	1/62	0.23477349240113526	0.2981116648115135	0	0	3.828929604628737	5.548632425072559	PTK2B
VEGFA Dependent Angiogenesis in Cancer	1/62	0.23477349240113526	0.2981116648115135	0	0	3.828929604628737	5.548632425072559	MYC
Natural Killer Cell Activation through ITAM-Containing Receptors	1/63	0.23807419374409589	0.301219320400236	0	0	3.7669829222011386	5.4062718629826785	PTK2B
Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway	1/64	0.24136082280652457	0.30406902784768397	0	0	3.7070028011204483	5.269364635462472	MYC
Proteins Involved in Hypertrophic Cardiomyopathy	1/65	0.24463343883496388	0.30406902784768397	0	0	3.6488970588235294	5.137626467495332	MYC
Clear Cell Endometrial Cancer and Papillary Serous Endometrial Cancer	1/65	0.24463343883496388	0.30406902784768397	0	0	3.6488970588235294	5.137626467495332	MYC
HPV Infection and Cancer	1/65	0.24463343883496388	0.30406902784768397	0	0	3.6488970588235294	5.137626467495332	MYC
Androgens in Sebocyte Maturation	1/65	0.24463343883496388	0.30406902784768397	0	0	3.6488970588235294	5.137626467495332	MYC
Neutrophil Recruitment and Priming	1/66	0.24789210093701325	0.30437909407233654	0	0	3.592579185520362	5.010791867835437	MYC
Platelet Activation via Adhesion Molecules	1/66	0.24789210093701325	0.30437909407233654	0	0	3.592579185520362	5.010791867835437	PTK2B
Vascular Endothelial Cell Activation by Cytokines	1/66	0.24789210093701325	0.30437909407233654	0	0	3.592579185520362	5.010791867835437	GNA14
Endothelial Cell Dysfunction in Pulmonary Hypertension	1/67	0.25113686786289574	0.30437909407233654	0	0	3.537967914438503	4.888612632693461	MYC
STAT3 and NFkB Activate Inflammation-Induced Tumorigenesis	1/67	0.25113686786289574	0.30437909407233654	0	0	3.537967914438503	4.888612632693461	MYC
Alveolar Epithelial Cell Dysfunction in COPD	1/67	0.25113686786289574	0.30437909407233654	0	0	3.537967914438503	4.888612632693461	PTK2B
Proteins Involved in Medulloblastoma	1/68	0.2543677981624342	0.30437909407233654	0	0	3.4849868305531166	4.770856483616748	MYC
Proteins Involved in Primary Ovarian Insufficiency	1/68	0.2543677981624342	0.30437909407233654	0	0	3.4849868305531166	4.770856483616748	INSIG2
Plasmin Effects in Inflammation	1/68	0.2543677981624342	0.30437909407233654	0	0	3.4849868305531166	4.770856483616748	PLAU
T-Cell Maturation (Hypothesis)	1/68	0.2543677981624342	0.30437909407233654	0	0	3.4849868305531166	4.770856483616748	MYC
Metabolic Effects of Oncogenes and Tumor Suppressor in Cancer Cells	1/68	0.2543677981624342	0.30437909407233654	0	0	3.4849868305531166	4.770856483616748	MYC
Osteoclast Activation in Multiple Myeloma	1/69	0.2575849502210434	0.30686099617671253	0	0	3.4335640138408303	4.657305832354093	MYC
Cholesteatoma	1/70	0.260788382019869	0.30686099617671253	0	0	3.3836317135549874	4.547756661251317	MYC
Chronic Myeloid Leukemia	1/70	0.260788382019869	0.30686099617671253	0	0	3.3836317135549874	4.547756661251317	MYC
Growth Factor Signaling in Pancreatic Neoplasms	1/70	0.260788382019869	0.30686099617671253	0	0	3.3836317135549874	4.547756661251317	MYC
Low-Grade Serous Ovarian Carcinoma	1/70	0.260788382019869	0.30686099617671253	0	0	3.3836317135549874	4.547756661251317	MYC
Pancreatic Neuroendocrine Tumors	1/71	0.2639781514229198	0.30958235033983617	0	0	3.335126050420168	4.442017496799639	MYC
Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway	1/72	0.2671543160230924	0.31123918665396577	0	0	3.287986743993372	4.3399084793012666	MYC
Glioma Stem Cell Program Activation	1/72	0.2671543160230924	0.31123918665396577	0	0	3.287986743993372	4.3399084793012666	MYC
TGFB Signaling activation by Blocking of Tumor Suppressors	1/73	0.27031693312159105	0.3138877545786896	0	0	3.242156862745098	4.241260511650994	MYC
Proteins Involved in Melanoma	2/238	0.27290405147655183	0.31444143045055345	0	0	1.9852703793381759	2.5781416097257774	PLAU;MYC
B-Cell Acute Lymphoblastic Leukemia	1/74	0.2734660599102547	0.31444143045055345	0	0	3.1975825946817085	4.1459144787075015	MYC
Myocardial Infarction	1/74	0.2734660599102547	0.31444143045055345	0	0	3.1975825946817085	4.1459144787075015	TIMP2
CXC Chemokine Receptor Signaling	1/75	0.2766017531435907	0.31496909309576615	0	0	3.1542130365659777	4.053720538658391	PTK2B
Glioma Invasion Signaling	1/75	0.2766017531435907	0.31496909309576615	0	0	3.1542130365659777	4.053720538658391	PLAU
Invadopodia Formation in Cancer Cells	1/75	0.2766017531435907	0.31496909309576615	0	0	3.1542130365659777	4.053720538658391	PTK2B
Endometrioid Ovarian Carcinoma	1/76	0.2797240695996395	0.3175003105102018	0	0	3.112	3.9645374645280653	MYC
Vitiligo	1/78	0.285928797233274	0.32350277379277476	0	0	3.030863254392666	3.7946785586949976	PTK2B
Clear Cell Ovarian Carcinoma	1/81	0.2951369645576914	0.33285414852672546	0	0	2.916764705882353	3.559373891413559	MYC
Growth Factor Signaling in Hepatocellular Carcinoma	1/82	0.2981801959831634	0.33309369994321736	0	0	2.8806100217864925	3.485703158576593	MYC
High-Grade Serous Ovarian Carcinoma	1/82	0.2981801959831634	0.33309369994321736	0	0	2.8806100217864925	3.485703158576593	MYC
Acute Myeloid Leukemia	1/82	0.2981801959831634	0.33309369994321736	0	0	2.8806100217864925	3.485703158576593	MYC
Proteins with Altered Expression in Cancer Metabolic Reprogramming	1/85	0.3072321872240103	0.3421229088015004	0	0	2.777310924369748	3.2776476730175657	MYC
Proteins Involved in Osteoarthritis	1/86	0.3102237984570717	0.3443679272180702	0	0	2.744498269896194	3.212329044289917	PLAU
Eosinophil Activation	1/87	0.31320264045302676	0.3465847400624402	0	0	2.7124487004103965	3.1488949448167403	GNA14
Proteins Involved in HIV Type 1 Infection	1/88	0.3161687670465563	0.3476871488082067	0	0	2.681135902636917	3.087272050064292	PLAU
Smooth Muscle Cell Dysfunction in Pulmonary Hypertension	1/88	0.3161687670465563	0.3476871488082067	0	0	2.681135902636917	3.087272050064292	NFATC3
Epithelial to Mesenchymal Transition in Cancer: Overview	1/90	0.3220630883751708	0.3530691621007307	0	0	2.6206212822207533	2.969184421732711	PTK2B
Proteins Involved in Epilepsy	2/270	0.32374307420150816	0.3538120903812148	0	0	1.7453802416488984	1.968448665755726	EPM2A;KCNMA1
Diffuse Large-B-Cell Lymphoma	1/91	0.32499138972030267	0.35408012521995935	0	0	2.591372549019608	2.9125902540604933	MYC
Endometrioid Endometrial Cancer	1/92	0.32790718892886034	0.35615765443657754	0	0	2.5627666451195865	2.8575480358922407	MYC
ESR1/ERBB Positive Luminal Breast Cancer	1/93	0.33081053867204613	0.3582089575191174	0	0	2.534782608695652	2.8040004962252554	MYC
Proteins Involved in Pancreatic Cancer	1/94	0.33370149159207996	0.3602343319021536	0	0	2.5074003795066413	2.7518930372832235	MYC
Proteins Involved in Diabetes Mellitus Type 1	1/97	0.34230049098939735	0.3672707395722105	0	0	2.4286764705882353	2.6037021954467265	CYP27B1
Proteins Involved in Polycystic Kidney Disease	1/97	0.34230049098939735	0.3672707395722105	0	0	2.4286764705882353	2.6037021954467265	MYC
Proteins Involved in Colorectal Neoplasms	1/99	0.3479721261088416	0.37222472883763963	0	0	2.378871548619448	2.511215071130418	MYC
Medulloblastoma	1/104	0.361940593415089	0.3859970679018925	0	0	2.2628212450028555	2.2996490843913855	MYC
Mantle Cell Lymphoma	1/105	0.364698585699192	0.3871880969994497	0	0	2.240950226244344	2.2604107705817387	MYC
Proteins Involved in Obesity	1/106	0.36744479460287716	0.3871880969994497	0	0	2.2194957983193278	2.22211966490254	MYC
Endometrial Cancer	1/106	0.36744479460287716	0.3871880969994497	0	0	2.2194957983193278	2.22211966490254	MYC
Apoptosis Evasion in Cancer: Overview	1/106	0.36744479460287716	0.3871880969994497	0	0	2.2194957983193278	2.22211966490254	ARHGEF3
Cell Cycle Overiew	1/107	0.37017926993788686	0.38890857823831565	0	0	2.1984461709211987	2.1847451847158346	MYC
Breast Cancer	1/108	0.37290206126650144	0.3906066101693621	0	0	2.177789994502474	2.148257995201809	MYC
Ca2+ Flux Regulation	1/109	0.3756132178677732	0.3922824435127927	0	0	2.157516339869281	2.112629947971675	PTK2B
Hepatocellular Carcinoma	1/112	0.3836773699000366	0.39834738698444977	0	0	2.098887122416534	2.0106357656935216	MYC
Genes with Mutations in Cancer-Associated Sustaining of Proliferative Signaling	1/112	0.3836773699000366	0.39834738698444977	0	0	2.098887122416534	2.0106357656935216	MYC
Pancreatic Ductal Carcinoma	1/117	0.39688947498264887	0.41085626002602654	0	0	2.0079107505070994	1.855505179479242	MYC
Metastatic Colorectal Cancer	1/121	0.4072572721420906	0.42035619025192394	0	0	1.9405882352941177	1.743250157166395	MYC
Receptors and Adaptor Proteins Activated in Cancer	1/125	0.417448878008937	0.42961939923368736	0	0	1.8776091081593929	1.6402665305040176	PLAU
Proteins Involved in Retinitis Pigmentosa	1/127	0.42247953594920096	0.43353277962229053	0	0	1.8476190476190477	1.5919349350699237	NRL
Proteins Involved in Hepatocellular Carcinoma	1/130	0.42994512028677295	0.43864343196887534	0	0	1.8043775649794802	1.5230709627789967	MYC
Ovarian Cancer	1/130	0.42994512028677295	0.43864343196887534	0	0	1.8043775649794802	1.5230709627789967	MYC
Neuroblastoma	1/131	0.43241238866754017	0.43988925994133055	0	0	1.7904072398190045	1.5010336413104233	MYC
Proteins Involved in Ulcerative Colitis	1/141	0.456511847532617	0.4630709258017638	0	0	1.6616806722689075	1.3029913230800254	MYC
Nociception Expression Targets Signaling	1/143	0.4612089470988867	0.4664950095298195	0	0	1.6381110190555095	1.2677408194346094	PTK2B
Proteins Involved in Diabetic Nephropathy	1/175	0.5311290895912932	0.535681624644933	0	0	1.3346855983772818	0.8445225535654248	TIMP2
Proteins Involved in Amyotrophic Lateral Sclerosis	1/181	0.5432026318076294	0.5462978034988409	0	0	1.2898039215686274	0.7871323251434355	PLAU
Proteins Involved in Atherosclerosis	1/200	0.5794442849420854	0.5810904334788528	0	0	1.1655335501034585	0.636015065932131	PLAU
Proteins Involved in Myocarditis	1/207	0.5920673158482584	0.5920673158482584	0	0	1.1255282695602513	0.589928693564302	PLAU
